Table 1.
Characterization of AR amino acid composition regarding theoretically phosphorylable residues.
| Total AA | Serine | Theonine | Tyrosine | S/T/Y | Percentage | Pro-Ser | Pro-Thr | |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Human AR | 919 | 81 | 37 | 33 | 151 | %16.43 | 7 | 2 |
| Chimpanzee AR | 911 | 81 | 37 | 33 | 151 | %16.58 | 7 | 2 |
| Mouse AR | 899 | 87 | 35 | 34 | 156 | %17.35 | 7 | 2 |
| Rat AR | 902 | 92 | 33 | 33 | 158 | %17.52 | 7 | 2 |
|
| ||||||||
| Human AR NTD | 537 | 56 | 20 | 20 | 96 | %17.88 | 6 | 1 |
| Human AR DBD | 90 | 4 | 5 | 5 | 14 | %15.56 | 0 | 0 |
| Human AR Hinge domain | 45 | 4 | 6 | 1 | 11 | %24.44 | 1 | 0 |
| Human AR LBD | 247 | 17 | 6 | 7 | 30 | %12.15 | 0 | 1 |
GenBank entry: human AR (M20132.1); chimpanzee AR (NM_001009012.1); mouse AR (NM_013476.3); and rat AR (NM_012502.1). AA: amino acid; S: Serine/Ser; T: Threonine/Thr; Y: Tyrosine/Tyr.